1-3 of 3
N. Vora
Close
Sort by
Journal Articles

Final Report on Tandem Autologous Stem Cell Transplantation for Patients with Primary Progressive or Poor Risk Recurrent Hodgkin Lymphoma - A Two Institution Study.

Henry C. Fung, MB, ChB, Patrick Stiff, MD, A. Nademanee, MD, E. Smith, MD, C. Cutrone, MD, M. Parthasarathy, MD, A. Krishnan, MD, J. Klein, MD, A. Molina, MD, C. Ruel, MD, D. Smith, PhD, T. Rodriquez, MD, P. Falk, MD, A. Toor, MD, J. Schriber, MD, J. Rosenthal, MD, B. Ivers, G. Somlo, MD, N. Kogut, MD, N. Vora, MD, K. Margolin, MD, R. Spielberger, MD, Stephen J. Forman, MD
Journal: Blood
Blood (2005) 106 (11): 2071.
https://doi.org/10.1182/blood.V106.11.2071.2071
Published: 2005
Journal Articles

Long Term Survival after ASCT for AML: Multivariate Analysis Shows Adverse Effect of Collecting and Infusing Larger Numbers of CD 34 Positive Cells.

Clarence B. Sarkodee-Adoo, MD, FACP, Anthony S. Stein, MD, Margaret R. O’Donnell, MD, Ravi M. Bhatia, MD, E. Bolotin, MD, K. P. Chang, MD, Mark Kirschbaum, MD, Neil Kogut, MD, Auayporn Nademanee, MD, Pablo Parker, MD, Vinod Pullarkat, MD, David Snyder, MD, Ricardo Spielberger, MD, Marilyn L. Slovak, MD, Joseph Alvarnas, MD, Joy Fridey, MD, Jeffrey Schriber, MD, Eileen Smith, MD, Andy Dagis, J. Land, J. Palmer, N. Vora, Stephen Forman, MD FACP
Journal: Blood
Blood (2005) 106 (11): 2921.
https://doi.org/10.1182/blood.V106.11.2921.2921
Published: 2005
Journal Articles

Analysis of Long Term Outcome in Autologous Stem Cell Transplant (ASCT) for Acute Myelogenous Leukemia (AML) in First Remission (CR1) - a 15 Year Experience.

Anthony Selwyn Stein, MD, M. O’Donnell, MD, P. Parker, MD, R. Spielberger, MD, A. Nademanee, MD, R. Bhatia, MD, D. S. Snyder, MD, M. Kirschbaum, MD, V. Pullarkat, MD, N. Kogut, MD, E. Bolotin, MD, K. Chang, MD, C. Sarkodee-Adoo, MD, M. Slovak, MD, N. Vora, MD, J. Land, RN, A. Dagis, J. Palmer, S. J. Forman, MD
Journal: Blood
Blood (2004) 104 (11): 1870.
https://doi.org/10.1182/blood.V104.11.1870.1870
Published: 2004